Clinical Efficacy and Safety of Bevacizumab, Apatinib, and Recombinant Human Endothelial Inhibitor in the Treatment of Advanced Gastric Cancer

OBJECTIVE: To investigate the clinical efficacy and safety of bevacizumab, apatinib, and recombinant human endothelial inhibitor in the treatment of advanced gastric cancer. METHODS: The medical data of 204 patients with a medium to advanced gastric cancer assessed for eligibility treated in our hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liang, Li, Wei, Liu, Ya-Gang, Zhang, Cui, Gao, Wei-Na, Gao, Li-Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894022/
https://www.ncbi.nlm.nih.gov/pubmed/35251174
http://dx.doi.org/10.1155/2022/6189833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894022/
https://www.ncbi.nlm.nih.gov/pubmed/35251174
http://dx.doi.org/10.1155/2022/6189833

Ejemplares similares